A Proactive Approach to Smoking Cessation in an HIV Clinic: Results of a Pilot Trial

A 12-week pharmacotherapy-based algorithm treatment resulted in more quit attempts and a greater reduction in smoking than standard therapy.

Smoking is common among HIV-infected patients in the U.S. and is a major threat to their health. To date, efforts to broadly decrease smoking in this population have yielded disappointing results. In a recent study involving patients identified as smokers in their medical records at a university HIV clinic, researchers compared a proactive pharmacotherapy-based algorithm intervention (an approach that has been effective in conditions such as hyperglycemia) with standard therapy.

One hundred HIV-infected active smokers were randomized to receive either a 12-week pharmacotherapy-based algorithm treatment offered promptly or treatment as usual (i.e., smoking-cessation assistance from the patient's medical provider when the patient was ready to …

Reviewing Author

Keith Henry, MD

Disclosures

Consultant/Advisory BoardViiV Advisory Board

Editorial BoardsJAIDS: Journal of Acquired Immune Deficiency Syndromes

Keith Henry, MD

Disclosures

Consultant/Advisory BoardViiV Advisory Board

Editorial BoardsJAIDS: Journal of Acquired Immune Deficiency Syndromes

A Proactive Approach to Smoking Cessation in an HIV Clinic: Results of a Pilot Trial

Topics

Reviewing Author